Literature DB >> 2916786

Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma.

R M McNamara1, W H Spivey, E Skobeloff, S Jacubowitz.   

Abstract

IV magnesium sulfate was administered to a 72-year-old man with acute respiratory failure secondary to a severe asthma attack. The patient had clinically deteriorated despite aggressive standard treatment and evidenced acidosis and hypercarbia by arterial blood gas determination. An IV dose of 1 g MgSO4 produced rapid clinical and arterial blood gas improvement and enabled management of the patient without endotracheal intubation and mechanical ventilation. This is the first reported case of the use of IV MgSO4 to prevent intubation and assisted ventilation in a patient with acute respiratory failure complicating asthma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916786     DOI: 10.1016/s0196-0644(89)80114-3

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

1.  Dose-response relationship and time-course of the effect of inhaled magnesium sulphate on airflow in normal and asthmatic subjects.

Authors:  J Hill; J Britton
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

Review 2.  The pulmonary physician in critical care . 12: Acute severe asthma in the intensive care unit.

Authors:  P Phipps; C S Garrard
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

3.  Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks.

Authors:  P Fantidis; J Ruiz Cacho; M Marín; R Madero Jarabo; J Solera; E Herrero
Journal:  J R Soc Med       Date:  1995-08       Impact factor: 5.344

4.  Magnesium sulfate for acute asthma in adults: a systematic literature review.

Authors:  Woo-Jung Song; Yoon-Seok Chang
Journal:  Asia Pac Allergy       Date:  2012-01-31

5.  Short and long term treatment of asthma with intravenous nutrients.

Authors:  Welman A Shrader
Journal:  Nutr J       Date:  2004-05-14       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.